ArticleHuman vaccines & immunotherapeutics2026
Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Oropharyngeal cancer mortality in the United States, 1999-2023: a surveillance analysis using CDC WONDER.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While sociodemographic differences in the population awareness of the link between HPV and HPV-associated cancers have been observed in the US, it is unclear how cancer type and gender contribute to these differences. We examined variations in US adults' awareness of the link between HPV and HPV-related cancers over time according to gender. We used data from the 2014-2020 Health Information National Trends Survey. Exposure was gender (men versus women), and outcomes were self-reported awareness of the causal link between HPV and cancers (cervical, anal, penile and oral cancer). A total of 10,933 participants were included in this study. Awareness of the link between HPV and cervical cancer was high (77.6% in 2014) but decreased by 7.4% between 2014 and 2020. In contrast, awareness of the link between HPV and anal, oral, and penile cancers was low (around 30% for each cancer type) and remained stable between 2014 and 2020. From 2014 to 2020, gender difference gradually widened for cervical cancer (with higher awareness among women versus men) while it gradually faded for anal cancer (with higher awareness among men versus women). For oral and penile cancers, the gender difference that was observed in 2014 (with higher awareness among men versus women) gradually narrowed and then reversed (with higher awareness among women versus men). These findings emphasize the importance of implementing novel and targeted interventions to enhance public knowledge of the HPV-cancer link, particularly for HPV-associated non-cervical cancers. Public health initiatives should focus on developing gender- and cancer type-specific educational campaigns aimed at mitigating misinformation around HPV and HPV-related cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.